STAT August 23, 2023
Dana Singiser

The Food and Drug Administration recently approved Opill, the first over-the-counter access birth control pill, in a monumental and long overdue win for reproductive and public health care. This FDA ruling will significantly expand access to high-quality contraception for folks across the country. However, true access will require affordability, too.

I had the honor of serving on the team in the Obama White House that tackled the challenge of making health insurance affordable to all under the Affordable Care Act. I had a front-row seat to see how women in Congress — led by Speaker Nancy Pelosi, Sen. Patty Murray, and especially former Sen. Barbara Mikulski — fought for coverage of women’s preventive services like mammograms, cervical cancer screenings, prenatal...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
The Evidence for Gratitude and Health, 2024 Giving Thanks
How 3 Health Systems Are Scaling Hybrid & Home-Based Models
277 million patients' data drives Epic's research findings
Growing gulf in US life expectancy deepened by COVID-19 pandemic

Share This Article